Trending...
- Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It
- Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
RALEIGH, N.C., Jan. 26, 2024 /PRNewswire/ -- The Board of Directors (the "Board") of First Citizens BancShares, Inc. ("BancShares") (NASDAQ: FCNCA) declared on Jan. 24, 2024, dividends on the company's Class A and Class B common stock, as well as Series A, B and C preferred stock for the period commencing on and including the last respective payment date.
ABOUT FIRST CITIZENS BANCSHARES
More on ncarol.com
First Citizens BancShares, Inc. (NASDAQ: FCNCA), a top 20 U.S. financial institution with more than $200 billion in assets, is the financial holding company for First-Citizens Bank & Trust Company ("First Citizens Bank"). Headquartered in Raleigh, N.C., First Citizens Bank has built a unique legacy of strength, stability and long-term thinking that has spanned generations. First Citizens offers an array of general banking services including a network of more than 500 branches and offices in 30 states; commercial banking expertise delivering best-in-class lending, leasing and other financial services coast to coast; innovation banking serving businesses at every stage; and a nationwide direct bank. Discover more at firstcitizens.com.
SOURCE First Citizens BancShares, Inc.
- As noted above, the Board declared a quarterly dividend of $1.64 per share on the company's Class A and Class B common stock. The dividend is payable March 15, 2024, to holders of record as of Feb. 29, 2024.
- The Board declared a regular quarterly dividend of $13.4375 per share on the company's 5.375% non-cumulative perpetual preferred stock, Series A (resulting in a distribution of $0.335938 per depositary share), to be paid on March 15, 2024, to holders of record as of Feb. 29, 2024.
- The Board declared a dividend of $24.0456 per share on the company's fixed-to-floating rate, non-cumulative perpetual preferred stock, Series B, to be paid on March 15, 2024, to holders of record as of Feb. 29, 2024. BancShares will pay the non-cumulative quarterly cash dividend at a rate of 9.61824%, which is equal to the three-month CME Term Secured Overnight Financing Rate ("SOFR") on the dividend determination date plus the applicable SOFR tenor spread adjustment of 0.26161% and a spread of 3.972%.
- Also, the Board declared a regular quarterly dividend of $0.351563 per share on the company's 5.625% non-cumulative perpetual preferred stock, Series C, to be paid on March 15, 2024, to holders of record as of Feb. 29, 2024.
ABOUT FIRST CITIZENS BANCSHARES
More on ncarol.com
- Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
- eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
- Creative Investment Research Welcomes Supreme Court Decision Protecting Federal Reserve Independence While Calling for Continued Accountability
- New from Regal House Publishing, The Reel Life of Zara Kegg: Love, grief, Godzilla, odd beach winter
- Ascent Solar Technologies (N A S D A Q: ASTI): Positioned at the Intersection of the New Space Economy, Defense Innovation and Next-Generation Energy
First Citizens BancShares, Inc. (NASDAQ: FCNCA), a top 20 U.S. financial institution with more than $200 billion in assets, is the financial holding company for First-Citizens Bank & Trust Company ("First Citizens Bank"). Headquartered in Raleigh, N.C., First Citizens Bank has built a unique legacy of strength, stability and long-term thinking that has spanned generations. First Citizens offers an array of general banking services including a network of more than 500 branches and offices in 30 states; commercial banking expertise delivering best-in-class lending, leasing and other financial services coast to coast; innovation banking serving businesses at every stage; and a nationwide direct bank. Discover more at firstcitizens.com.
SOURCE First Citizens BancShares, Inc.
Filed Under: Business
0 Comments
Latest on ncarol.com
- Salt Lake City Families Turn to Private Autopsy Services for Faster Answers After Unexpected Loss
- K2 Integrity's U.S. and EMEA Teams Again Recognized in Chambers and Partners 2026 Guides
- Connecta Satellite Solutions Ready to Support Emergency Communications Following the Venezuela Earthquake
- Rare 1933 Harold Weston painting will be auctioned to benefit the Keene Valley Library
- $20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
- HomeCentris Home Health Achieves 5-Star CMS Rating
- Adsoptia Launches AI-Powered Optimization Platform for a New Era of Autonomous Marketing Decisions
- Heritage at Manalapan Announces New Incentive: Included Finished Basement on Select Homesites
- Leicester UK Manufacturer Tabletop Tyrant Secures Flawless 100% Customer Satisfaction Rating Across 5,800+ Orders
- The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth
- Cango Mobility x Hikvision Announce Strategic Partnership
- HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
- Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
- Custom Cushions and Sewing Solutions Available in Cleveland County and Surrounding Areas
- Century Fasteners de Mexico Exhibiting at 2026 Farnborough International Airshow
- George Martinez Completes Community Re-distribution Initiative, Returning $5,000 In Campaign Resources To Anchorage Nonprofits
- Mister Omaha Tries The Turf At Lone Star Park
- Andrew D. Levine Releases The Lily Network, an Indian Noir Mystery of Power, Paperwork & Murder
- The Mapping Software Behind America's Viral Maps Just Got Faster and Smarter
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases